Literature DB >> 20233642

Gene expression profiling of Pseudorabies virus (PrV) infected bovine cells by combination of transcript analysis and quantitative proteomic techniques.

Martin Skiba1, Frithjof Glowinski, Dirk Koczan, Thomas C Mettenleiter, Axel Karger.   

Abstract

Infection of target cells by alphaherpesviruses leads to extensive modulation of host cell gene expression. To gain detailed information on the molecular pathways affected by infection of Madin-Darby bovine kidney (MDBK) cells with PrV, transcript analysis was combined with a stable isotope-based quantitative proteomic approach (SILAC). Four hours after infection cells were harvested and processed in parallel either for transcript analysis, for subcellular fractionation into nuclei and cytosol, for extraction of phosphoproteins, or for affinity extraction with Heparin Sepharose and Cibacron Blue F3G-A-Sepharose. All fractions were further analysed by large format two-dimensional gel electrophoresis in different pH-ranges to maximize the number of proteins to be identified and quantified by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS). Cell fractionation was quick and easy to perform but in comparison to affinity fractionation yielded lower numbers of identified and quantified proteins. After infection with PrV, only two of the 55 proteins with significantly modulated protein levels showed significant changes in transcript levels, indicating that posttranslational modifications may play a major role in the cellular response to PrV infection. Application of isotope labelling to cell cultures infected with wild-type PrV-Ka and a US3 protein kinase negative mutant allowed to monitor pUS3-dependent changes in the expression levels of viral proteins pUL29, pUL39 and pUL42. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20233642     DOI: 10.1016/j.vetmic.2010.02.009

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  8 in total

Review 1.  Bioanalysis of eukaryotic organelles.

Authors:  Chad P Satori; Michelle M Henderson; Elyse A Krautkramer; Vratislav Kostal; Mark D Distefano; Mark M Distefano; Edgar A Arriaga
Journal:  Chem Rev       Date:  2013-04-10       Impact factor: 60.622

Review 2.  Investigating the biology of alpha herpesviruses with MS-based proteomics.

Authors:  Esteban A Engel; Ren Song; Orkide O Koyuncu; Lynn W Enquist
Journal:  Proteomics       Date:  2015-05-15       Impact factor: 3.984

3.  Low-pH Endocytic Entry of the Porcine Alphaherpesvirus Pseudorabies Virus.

Authors:  Jonathan L Miller; Darin J Weed; Becky H Lee; Suzanne M Pritchard; Anthony V Nicola
Journal:  J Virol       Date:  2019-01-04       Impact factor: 5.103

4.  iTRAQ-based Proteomic Analysis of Porcine Kidney Epithelial PK15 cells Infected with Pseudorabies virus.

Authors:  Songbai Yang; Yue Pei; Ayong Zhao
Journal:  Sci Rep       Date:  2017-04-04       Impact factor: 4.379

5.  Imaging Mass Spectrometry and Proteome Analysis of Marek's Disease Virus-Induced Tumors.

Authors:  V I Pauker; L D Bertzbach; A Hohmann; A Kheimar; J P Teifke; T C Mettenleiter; A Karger; B B Kaufer
Journal:  mSphere       Date:  2019-01-16       Impact factor: 4.389

Review 6.  Mass spectrometry based proteomic studies on viruses and hosts--a review.

Authors:  Jie Zheng; Richard J Sugrue; Kai Tang
Journal:  Anal Chim Acta       Date:  2011-06-30       Impact factor: 6.558

7.  Tandem Mass Tag-Based Quantitative Proteomic Analysis of ISG15 Knockout PK15 Cells in Pseudorabies Virus Infection.

Authors:  Wenfeng He; Chen Li; Liangliang Dong; Guoqing Yang; Huimin Liu
Journal:  Genes (Basel)       Date:  2021-09-30       Impact factor: 4.096

8.  Synaptic Inputs to the Mouse Dorsal Vagal Complex and Its Resident Preproglucagon Neurons.

Authors:  Marie K Holt; Lisa E Pomeranz; Kevin T Beier; Frank Reimann; Fiona M Gribble; Linda Rinaman
Journal:  J Neurosci       Date:  2019-10-30       Impact factor: 6.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.